Visit theperfect46.com, and it looks like any business web page. The Perfect 46 purports to be a company that uses the power of genomics, the information stored in the entirety of your DNA–your genome–to determine if you are with “the one” for you.
New genome sequencing recommendation will enable patients to opt out of testing
From designer babies to women whose genitals smell like peaches, 2014 graced us with a taste of the hope, hype and superficiality of business as usual in Silicon Valley.
"Mutants became objects of fear and hatred." — Kitty Pryde narrating in the story "Days of Future Past" found in The Uncanny X-Men #141 in January 1980 "In her DNA they found the key to her mutant power." — Professor X musing about how Mystique was used to derive special powers for the Sentinel army [...]
A review of Nicholas Wade’s book, “A Troublesome Inheritance: Genes, Race and Human History“. In this book NYT science writer Nicholas Wade advances two simple premises: firstly, that we should stop looking only toward culture as a determinant of differences between populations and individuals, and secondly, that those who claim that race is only a [...]
“Amborella trichopoda (3173820625)-2” by Amborella_trichopoda_(3173820625).jpg: Scott Zona from USA derivative work: Bff – Amborella_trichopoda_(3173820625).jpg.
As many mysteries as the octopus holds—its comprehensive camouflage, smart suckers, agile brain—its genome is surely holding many more (including how it can regenerate its arms—suckers, nerves and all).
In part 1 of this series, I talked about what DNA sequencing is, and why it’s an important tool. In part 2, I explained some of the technologies that scientists are currently using to actually “read” the letters of DNA sequences from organisms.
British biochemist Fred Sanger died today at 95. He’s the only person to win two Nobel Prizes in chemistry, an achievement that is unlikely to be surpassed anytime soon.
With 23andMe in the news this week, I thought it was a good time to share something I’d never published before. It’s a short interview with Linda Avey, co-founder of 23andMe.